Life sciences briefing: Thursday, Jan. 31, 2007
TODAY’S HEADLINES:
5AM Ventures puts $3.3M into stealthy ImmunoNewco (VBLS exclusive)
NewLink Genetics raises $17M for cancer vaccine, immune drugs (VBLS exclusive)
Biochip, stem-cell biotech Minerva Bio ousts CEO Jim Czirr and sues (release)
Sonexa Therapeutics takes $30M for Alzheimer’s treatment (release)
Tissue regenerator Healionics pulls in $1.7M (release)
EGeen, clinical research organization, receives $245K (VentureWire)
Barnvet Labs, HeMemics Bio get $75K apiece from Maryland gov’t (release)
5AM Ventures puts $3.3M into new immune-related startup – I’ve moved this item to a standalone post… Continue Reading
Micell: A materials chameleon tackles drug-coated devices
For Micell Technologies, a Raleigh, N.C., materials company that recently reinvented itself as a developer of drug-releasing stents, perhaps the third time will be the charm.
Founded in 1995, Micell specializes in the use of supercritical fluids, which are highly compressed gases that exhibit both gas and liquid properties. The company initially marketed liquefied carbon-dioxide systems to dry cleaners as an ecofriendly alternative to a solvent known as perchloroethylene. Its machines, however, were expensive, and Micell… Continue Reading